Hale Geoff | Department Of Pathology University Of Cambridge
スポンサーリンク
概要
関連著者
-
Hale Geoff
Department Of Pathology University Of Cambridge
-
BRADLEY John
Department of Chemistry, University of Hull
-
Bradley John
Department Of Chemistry University Of Hull
-
Moffatt Susan
Department Of Surgery Addenbrooke's Hospital
-
Waldmann Herman
Department Of Surgery Addenbrooke's Hospital
-
Firth John
Department Of Surgery Addenbrooke's Hospital
-
Calne Sir
Department of Surgery, Addenbrooke's Hospital
-
Friend Peter
Department of Surgery, Addenbrooke's Hospital
-
Jamieson Neville
Department of Surgery, Addenbrooke's Hospital
-
Bradley J.
Department of Surgery, Addenbrooke's Hospital
-
Hale Geoff
Department of Surgery, Addenbrooke's Hospital
-
Smith Ken
Department of Surgery, Addenbrooke's Hospital
-
Calne Sir
Department Of Surgery Addenbrooke's Hospital
-
Smith Ken
Department Of Surgery Addenbrooke's Hospital
-
Hale Geoff
Department Of Surgery Addenbrooke's Hospital
-
Friend Peter
Department Of Surgery Addenbrooke's Hospital
-
ROWAN Wendy
Molecular Immunology Section, Wellcome Research Labs.
-
TITE John
Molecular Immunology Section, Wellcome Research Labs.
-
BRETT Sara
Molecular Immunology Section, Wellcome Research Labs.
-
Jamieson Neville
Department Of Hepatobiliary And Transplant Surgery Addenbrooke's Hospital Cambridge University
-
Jamieson Neville
Department Of Surgery Addenbrooke's Hospital
-
Tite John
Molecular Immunology Group Wellcome Research Laboratories
-
Tite John
Molecular Immunology Section Wellcome Research Labs.
-
Brett Sara
Molecular Immunology Group Wellcome Research Laboratories
-
Brett Sara
Molecular Immunology Section Wellcome Research Labs.
-
Rowan Wendy
Molecular Immunology Group Wellcome Research Laboratories
-
Rowan Wendy
Molecular Immunology Section Wellcome Research Labs.
-
Bradley J.
Department Of Surgery Addenbrooke's Hospital
著作論文
- 2. PROPE TOLERANCE WITH INDUCTION USING CAMPATH 1H AND LOW-DOSE CYCLOSPORIN MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS(未来のための今 : 移植-次世紀への新たなるアプロ-チ)
- Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes